Inventor · disambiguated record
Markus Fiedler
Also filed as: FIEDLER MARKUS
14 granted patents·9 pending applications·101 citations·filing 2002–2023
92Inventor score
Top patents by PatentIndex Score
23 records- 0190US10717780B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2018·Granted Jul 21, 2020·5 cites·12 claims
- 0289US8790895B2Generation of artificial binding proteins on the basis of ubiquitin proteinsFIEDLER MARKUS·Filed 2005·Granted Jul 29, 2014·19 cites·27 claims
- 0386US8791238B2Artificial binding proteins based on ubiquitinFIEDLER MARKUS·Filed 2008·Granted Jul 29, 2014·11 cites·22 claims
- 0486US8426357B2Multimeric conjugateKRAEHMER RALF·Filed 2008·Granted Apr 23, 2013·20 cites·25 claims
- 0585US10989684B2Biosensor, process for its preparation and method for detecting an analyte using the biosensorFRAUNHOFER GES FORSCHUNG·Filed 2017·Granted Apr 27, 2021·4 cites·14 claims
- 0684US10093736B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2013·Granted Oct 9, 2018·7 cites·9 claims
- 0780US9461195B2Method for producing a solar cellFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V·Filed 2013·Granted Oct 4, 2016·3 cites·23 claims
- 0879US11046745B2Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereofBioNTech SE·Filed 2015·Granted Jun 29, 2021·3 cites·38 claims
- 0978US8921304B2Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectinSTEUERNAGEL ARND·Filed 2010·Granted Dec 30, 2014·10 cites·9 claims
- 1075US9492572B2Dimeric binding proteins based on modified ubiquitinsNERKAMP JOERG·Filed 2012·Granted Nov 15, 2016·7 cites·21 claims
- 1175US8748351B2Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligandsKUNERT ANJA·Filed 2010·Granted Jun 10, 2014·9 cites·13 claims
- 1275US2023406902A1Peptide mimotopes of claudin 18.2 and uses thereofBioNTech SE·Filed 2023·Application pending·0 cites
- 1374US2024228616A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2022·Application pending·0 cites
- 1470US11673939B2Compositions and methods for diagnosis and treatment of cancerBioNTech SE·Filed 2019·Granted Jun 13, 2023·1 cites·19 claims
- 1568US10858415B2Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2014·Granted Dec 8, 2020·1 cites·15 claims
- 1668US2024116013A1Processing system and method for processing an energy storage materialCOPERION GMBH·Filed 2023·Application pending·0 cites
- 1765US2020031898A1Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2019·Application pending·0 cites
- 1865US2020399370A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2020·Application pending·0 cites
- 1964US10370433B2Compositions and methods for diagnosis and treatment of cancerBIONTECH AG·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 2062US2024145665A1Process and arrangement for production of an electrode suspensionCOPERION GMBH·Filed 2023·Application pending·0 cites
- 2148US2006287501A1Soluble truncated polypeptides of the nogo-a proteinPIERIS PROTEOLAB AG·Filed 2002·Application pending·0 cites
- 2240US2007015248A1Expression vector and use thereofANTON ANDREAS·Filed 2006·Application pending·0 cites
- 2338US2015183846A1Human fusion proteins comprising single chain tnfalpha and targeting domainsSCIL PROTEINS GMBH·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Fiedler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →